These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3718589)

  • 1. Metabolic fate of the new cardiotonic denopamine in animals. 2nd communication: tissue accumulation in the rat after consecutive oral administration of 14C-denopamine.
    Naito K; Furuuchi S; Usuki S; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):652-5. PubMed ID: 3718589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
    Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of the new cardiotonic denopamine in animals. 4th communication: effects of coadministered drugs on the plasma concentration and metabolism of denopamine in dogs.
    Furuuchi S; Naito K; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):665-7. PubMed ID: 3718591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of the new cardiotonic denopamine in animals. 3rd communication: placental transfer and excretion into milk in the rat.
    Naito K; Furuuchi S; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):656-65. PubMed ID: 3718590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of the new anti-ulcer drug enprostil in animals. 3rd communication: tissue accumulation after consecutive oral administration of [3H]-enprostil in rats.
    Kohno M; Naito K; Yamada Y; Nakahara M; Otsuka M; Takaiti O; Parnes H; Chaplin M
    Arzneimittelforschung; 1989 Mar; 39(3):350-6. PubMed ID: 2502988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 3rd communication: tissue accumulation after consecutive oral administration of [N-methyl-14C]-imidapril in rats.
    Yamada Y; Endo M; Kohno M; Suzuki T; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):475-82. PubMed ID: 1642670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of denopamine, a new cardiotonic agent, in the rat and dog.
    Furuuchi S; Naito K; Otsuka M; Harigaya S
    Drug Metab Dispos; 1985; 13(5):620-6. PubMed ID: 2865114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between positive inotropic action and blood levels of denopamine in cats.
    Naito K; Otsuka M; Harigaya S; Nagao T; Narita H
    Arzneimittelforschung; 1985; 35(5):833-5. PubMed ID: 4026907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Tsutsumi S; Harada T; Miyoshi R; Inaba A
    Arzneimittelforschung; 1997 Feb; 47(2):195-200. PubMed ID: 9079240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro metabolism of the new cardiotonic agent denopamine (TA-064) by rat and rabbit liver preparations. Oxidation, methylation, and glucuronidation.
    Suzuki T; Hashimura Y; Takeyama S
    Drug Metab Dispos; 1985; 13(2):246-54. PubMed ID: 2859176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic studies of mabuterol, a new selective beta 2-stimulant. I: Studies on the absorption, distribution and excretion in rats.
    Yuge T; Hase T; Takayanagi Y; Kamasuka T; Amemiya K; Horiba M
    Arzneimittelforschung; 1984; 34(11A):1659-67. PubMed ID: 6152159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 2nd communication: tissue levels and enzyme activity in rats after repeated administration, and placental and milk transfer after single administration.
    Nakamura A; Hirota T; Sugihara K; Watanabe S; Tougou K; Morino A; Ezumi Y; Takaichi M
    Arzneimittelforschung; 1997 Feb; 47(2):160-8. PubMed ID: 9079235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of AR-L 115 BS in the rat (author's transl)].
    Busch U
    Arzneimittelforschung; 1981; 31(1a):204-9. PubMed ID: 7195222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
    Mukai H; Sugimoto T; Ago M; Morino A; Takaichi M; Ogawa Y; Seki H; Matsuura C; Esumi Y
    Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), in the rat, rabbit, beagle dog and rhesus monkey.
    Miyamoto G; Sasabe H
    Arzneimittelforschung; 1984; 34(3A):394-402. PubMed ID: 6540095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.